 Quanbin Xu
Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle Proteins | 8 | 2016 | 614 | 1.710 |
Why?
| | Protein-Tyrosine Kinases | 8 | 2016 | 434 | 1.510 |
Why?
| | Spindle Apparatus | 4 | 2014 | 102 | 1.120 |
Why?
| | Kinetochores | 3 | 2013 | 53 | 0.780 |
Why?
| | Transforming Growth Factor alpha | 2 | 2010 | 57 | 0.680 |
Why?
| | ErbB Receptors | 2 | 2010 | 616 | 0.530 |
Why?
| | Colonic Neoplasms | 2 | 2016 | 258 | 0.480 |
Why?
| | Mitosis | 3 | 2016 | 193 | 0.480 |
Why?
| | Receptors, Cell Surface | 1 | 2016 | 391 | 0.430 |
Why?
| | Aneuploidy | 1 | 2014 | 93 | 0.430 |
Why?
| | Metaphase | 1 | 2013 | 31 | 0.410 |
Why?
| | M Phase Cell Cycle Checkpoints | 2 | 2016 | 24 | 0.400 |
Why?
| | Cell Line, Tumor | 9 | 2024 | 3420 | 0.360 |
Why?
| | Superantigens | 1 | 2010 | 70 | 0.350 |
Why?
| | Ultraviolet Rays | 1 | 2013 | 389 | 0.330 |
Why?
| | Melanoma, Experimental | 1 | 2010 | 113 | 0.330 |
Why?
| | Enterotoxins | 1 | 2010 | 87 | 0.330 |
Why?
| | Adaptor Proteins, Signal Transducing | 4 | 2015 | 429 | 0.320 |
Why?
| | Cell Division | 1 | 2011 | 795 | 0.320 |
Why?
| | Epidermal Growth Factor | 1 | 2010 | 174 | 0.320 |
Why?
| | Blood Pressure | 1 | 2016 | 1776 | 0.300 |
Why?
| | Signal Transduction | 7 | 2016 | 5096 | 0.300 |
Why?
| | Cancer Vaccines | 1 | 2010 | 173 | 0.290 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2011 | 455 | 0.290 |
Why?
| | Vesiculovirus | 3 | 2024 | 16 | 0.270 |
Why?
| | RNA, Small Interfering | 4 | 2020 | 621 | 0.260 |
Why?
| | Immunotherapy | 1 | 2010 | 647 | 0.250 |
Why?
| | Thiazoles | 2 | 2018 | 123 | 0.230 |
Why?
| | Carbanilides | 1 | 2024 | 3 | 0.220 |
Why?
| | Ubiquitination | 2 | 2015 | 104 | 0.220 |
Why?
| | Brain | 1 | 2016 | 2831 | 0.210 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2015 | 123 | 0.200 |
Why?
| | HEK293 Cells | 4 | 2024 | 734 | 0.200 |
Why?
| | Recombinant Fusion Proteins | 3 | 2010 | 665 | 0.200 |
Why?
| | Amino Acid Motifs | 2 | 2015 | 225 | 0.200 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2024 | 179 | 0.190 |
Why?
| | Phosphorylation | 6 | 2014 | 1762 | 0.190 |
Why?
| | Protein Kinases | 1 | 2024 | 319 | 0.190 |
Why?
| | Gene Editing | 1 | 2020 | 82 | 0.160 |
Why?
| | Exosomes | 1 | 2020 | 103 | 0.160 |
Why?
| | Down-Regulation | 2 | 2014 | 658 | 0.160 |
Why?
| | Gene Transfer Techniques | 1 | 2020 | 169 | 0.160 |
Why?
| | Depsipeptides | 1 | 2018 | 14 | 0.140 |
Why?
| | TNF Receptor-Associated Factor 3 | 2 | 2015 | 5 | 0.140 |
Why?
| | Histone Code | 1 | 2018 | 34 | 0.140 |
Why?
| | Voltage-Dependent Anion Channel 1 | 2 | 2016 | 10 | 0.140 |
Why?
| | Viral Proteins | 2 | 2024 | 346 | 0.140 |
Why?
| | Protein Structure, Tertiary | 3 | 2015 | 869 | 0.140 |
Why?
| | Amino Acid Sequence | 3 | 2010 | 2146 | 0.130 |
Why?
| | Enhancer Elements, Genetic | 1 | 2018 | 190 | 0.130 |
Why?
| | Renin | 1 | 2016 | 34 | 0.130 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2901 | 0.130 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2018 | 211 | 0.130 |
Why?
| | Animals | 11 | 2024 | 37011 | 0.120 |
Why?
| | Angiotensin II | 1 | 2016 | 99 | 0.120 |
Why?
| | Renin-Angiotensin System | 1 | 2016 | 84 | 0.120 |
Why?
| | Cell Line | 5 | 2018 | 2852 | 0.120 |
Why?
| | Immunity, Innate | 4 | 2014 | 832 | 0.120 |
Why?
| | Interphase | 1 | 2015 | 32 | 0.120 |
Why?
| | Karyopherins | 1 | 2015 | 18 | 0.120 |
Why?
| | Mitochondria | 2 | 2024 | 947 | 0.110 |
Why?
| | Humans | 18 | 2024 | 137514 | 0.110 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2015 | 98 | 0.110 |
Why?
| | Protein Binding | 3 | 2016 | 2229 | 0.110 |
Why?
| | Enterovirus A, Human | 1 | 2014 | 12 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 188 | 0.110 |
Why?
| | Oligopeptides | 1 | 2016 | 273 | 0.110 |
Why?
| | Cytoplasm | 1 | 2015 | 274 | 0.110 |
Why?
| | Mice | 8 | 2024 | 17843 | 0.110 |
Why?
| | Immune Evasion | 1 | 2014 | 58 | 0.110 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 373 | 0.110 |
Why?
| | DEAD-box RNA Helicases | 1 | 2014 | 76 | 0.110 |
Why?
| | Inflammasomes | 1 | 2015 | 128 | 0.110 |
Why?
| | RNA Interference | 2 | 2015 | 464 | 0.110 |
Why?
| | Mice, Inbred C57BL | 4 | 2015 | 5792 | 0.100 |
Why?
| | Protein Transport | 1 | 2015 | 443 | 0.100 |
Why?
| | Time-Lapse Imaging | 1 | 2013 | 21 | 0.100 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 220 | 0.100 |
Why?
| | Tamoxifen | 1 | 2014 | 202 | 0.100 |
Why?
| | Caspase 3 | 1 | 2013 | 246 | 0.100 |
Why?
| | Antihypertensive Agents | 1 | 2016 | 493 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 386 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2016 | 708 | 0.090 |
Why?
| | Viral Envelope Proteins | 2 | 2024 | 84 | 0.090 |
Why?
| | Cell Nucleus | 1 | 2015 | 615 | 0.090 |
Why?
| | G2 Phase | 1 | 2011 | 38 | 0.090 |
Why?
| | Tyrosine | 1 | 2012 | 224 | 0.090 |
Why?
| | Chromosome Segregation | 1 | 2011 | 47 | 0.090 |
Why?
| | G1 Phase | 1 | 2010 | 71 | 0.080 |
Why?
| | Blotting, Western | 1 | 2013 | 1227 | 0.080 |
Why?
| | Quinolines | 1 | 2011 | 180 | 0.080 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 2009 | 13 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 501 | 0.080 |
Why?
| | Random Allocation | 1 | 2010 | 357 | 0.080 |
Why?
| | Interferon-beta | 1 | 2009 | 92 | 0.080 |
Why?
| | Mad2 Proteins | 1 | 2008 | 5 | 0.080 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 957 | 0.080 |
Why?
| | Spleen | 1 | 2010 | 516 | 0.070 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2014 | 806 | 0.070 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2009 | 156 | 0.070 |
Why?
| | Immunization | 1 | 2010 | 414 | 0.070 |
Why?
| | MicroRNAs | 1 | 2014 | 704 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2008 | 218 | 0.070 |
Why?
| | Apoptosis | 2 | 2013 | 2557 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2009 | 257 | 0.070 |
Why?
| | Hypertension | 1 | 2016 | 1293 | 0.070 |
Why?
| | Escherichia coli | 1 | 2010 | 815 | 0.060 |
Why?
| | Repressor Proteins | 1 | 2008 | 425 | 0.060 |
Why?
| | HeLa Cells | 2 | 2020 | 640 | 0.060 |
Why?
| | Albumins | 1 | 2024 | 114 | 0.050 |
Why?
| | Glycoproteins | 1 | 2024 | 345 | 0.050 |
Why?
| | Vesicular Stomatitis | 2 | 2013 | 3 | 0.050 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 146 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2014 | 2249 | 0.040 |
Why?
| | Argonaute Proteins | 1 | 2020 | 27 | 0.040 |
Why?
| | Caspase 9 | 1 | 2020 | 57 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 50 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2024 | 363 | 0.040 |
Why?
| | Host-Pathogen Interactions | 2 | 2014 | 367 | 0.040 |
Why?
| | Integrases | 1 | 2020 | 121 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 2 | 2014 | 328 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2020 | 394 | 0.040 |
Why?
| | Cytostatic Agents | 1 | 2018 | 6 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2010 | 816 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 145 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1271 | 0.040 |
Why?
| | Oncogenes | 1 | 2018 | 117 | 0.030 |
Why?
| | Acetylation | 1 | 2018 | 254 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2015 | 3020 | 0.030 |
Why?
| | Polyploidy | 1 | 2016 | 19 | 0.030 |
Why?
| | Histone Deacetylases | 1 | 2018 | 215 | 0.030 |
Why?
| | Cytokinesis | 1 | 2016 | 48 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2024 | 3292 | 0.030 |
Why?
| | Genome | 1 | 2018 | 292 | 0.030 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 21 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 155 | 0.030 |
Why?
| | Polyubiquitin | 1 | 2014 | 6 | 0.030 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2014 | 3 | 0.030 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2014 | 14 | 0.030 |
Why?
| | DEAD Box Protein 58 | 1 | 2014 | 9 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2018 | 324 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 370 | 0.030 |
Why?
| | Immunoblotting | 1 | 2015 | 307 | 0.030 |
Why?
| | Vero Cells | 1 | 2014 | 67 | 0.030 |
Why?
| | Cysteine Endopeptidases | 1 | 2014 | 72 | 0.030 |
Why?
| | Phosphoserine | 1 | 2014 | 34 | 0.030 |
Why?
| | Cyclin D1 | 1 | 2014 | 67 | 0.030 |
Why?
| | Interferon Type I | 1 | 2014 | 142 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 402 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2066 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2013 | 48 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1255 | 0.030 |
Why?
| | Dogs | 1 | 2014 | 411 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 2014 | 223 | 0.030 |
Why?
| | Cell Survival | 1 | 2016 | 1122 | 0.030 |
Why?
| | TNF Receptor-Associated Factor 6 | 1 | 2012 | 4 | 0.020 |
Why?
| | Protein Stability | 1 | 2013 | 178 | 0.020 |
Why?
| | Virus Diseases | 1 | 2015 | 217 | 0.020 |
Why?
| | Estrogen Receptor alpha | 1 | 2014 | 144 | 0.020 |
Why?
| | Histones | 1 | 2018 | 641 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 193 | 0.020 |
Why?
| | Liver | 1 | 2020 | 1940 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2014 | 892 | 0.020 |
Why?
| | Virus Replication | 1 | 2014 | 480 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 846 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2838 | 0.020 |
Why?
| | Catalysis | 1 | 2010 | 319 | 0.020 |
Why?
| | Mutation | 2 | 2010 | 3964 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2009 | 385 | 0.020 |
Why?
| | Protein Subunits | 1 | 2009 | 238 | 0.020 |
Why?
| | Fibroblasts | 1 | 2013 | 990 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1458 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1357 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1548 | 0.020 |
Why?
| | Protein Conformation | 1 | 2009 | 930 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2615 | 0.010 |
Why?
| | Models, Molecular | 1 | 2009 | 1586 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2009 | 1167 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4206 | 0.010 |
Why?
| | Female | 2 | 2020 | 73162 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2014 | 10821 | 0.010 |
Why?
|
|
Xu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|